Related Experiment Videos

Working conference on biomodulator and chemotherapy combination therapies

T D Brown¹, M S Mitchell, R Pazdur

¹Department of Medicine/Oncology, University of Texas Health Science Center, San Antonio 78284.

Investigational New Drugs

|May 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

External control arms in oncology: current use and future directions.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

A Food and Drug Administration analysis of survival outcomes comparing the Adjuvant Paclitaxel and Trastuzumab trial with an external control from historical clinical trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science.

Clinical pharmacology and therapeutics·2017

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Non-Small Cell Lung Cancer.

Clinical pharmacology and therapeutics·2016

See all related articles